Ads
related to: stelara for crohn's disease- STELARA® Dosing
Dosing & Administration
Important Safety Info
- STELARA® Videos
View Short Educational Videos
to Help Inform Patient Care.
- Patient Resources
Visit HCP Site to
Find Resources for Your Patients.
- STELARA® Support
Find Cost & Support Resources to
Help Patients With Their Treatment
- Info for Physicians
Physicians - Find Safety, Dosing
& Clinical Data for STELARA®.
- Practice Resources
Visit HCP Site to
Find Resources for Your Practice.
- STELARA® Dosing
Search results
IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
Investor's Business Daily· 36 minutes agoEli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising...
From Nurse To Patient: My Journey With Crohn’s Disease
Women's Health via Yahoo News· 2 years agoAs a healthcare professional, Alison spent her days doing endoscopies, which are one of the many...
AbbVie's (ABBV) Skyrizi Crohn's Disease Study Meets Goals
Zacks via Yahoo Finance· 8 months agoAbbVie's (ABBV) Skyrizi met both primary endpoints of non-inferiority for clinical remission at week...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 5 hours agoJohnson and Johnson (J&J) has announced positive data from the Phase III QUASAR maintenance trial...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 1 year agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks via Yahoo Finance· 2 months agoBristol Myers BMY announced that a late-stage study on orally-administered Zeposia (ozanimod) in...
Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast
Reuters via Yahoo News· 12 months agoJohnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster...
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
Johnson & Johnson Clocks 12% Q4 Revenue Growth, Led By Cancer and Crohn's Disease Drugs
Benzinga via Yahoo Finance· 4 months agoOn Tuesday, Johnson & Johnson (NYSE:JNJ) reported fourth-quarter 2023 adjusted earnings of $2.29 per...
Lilly's bowel disease drug succeeds in late-stage study
Reuters via Yahoo News· 7 months agoThe drug was also shown not to be inferior to Johnson & Johnson's Stelara in helping symptoms of the...
Ad
related to: stelara for crohn's disease